268 related articles for article (PubMed ID: 32765524)
1. The CD28 Transmembrane Domain Contains an Essential Dimerization Motif.
Leddon SA; Fettis MM; Abramo K; Kelly R; Oleksyn D; Miller J
Front Immunol; 2020; 11():1519. PubMed ID: 32765524
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of a dimerization interface in the CD28 transmembrane domain.
Wu H; Cao R; Wen M; Xue H; OuYang B
Structure; 2022 Jun; 30(6):803-812.e5. PubMed ID: 35397202
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor signaling can directly enhance the avidity of CD28 ligand binding.
Sanchez-Lockhart M; Rojas AV; Fettis MM; Bauserman R; Higa TR; Miao H; Waugh RE; Miller J
PLoS One; 2014; 9(2):e89263. PubMed ID: 24586641
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: A role for inside-out signaling in TCR regulation of CD28 ligand binding.
Sanchez-Lockhart M; Kim M; Miller J
J Immunol; 2011 Dec; 187(11):5515-9. PubMed ID: 22068237
[TBL] [Abstract][Full Text] [Related]
5. Constitutively oxidized CXXC motifs within the CD3 heterodimeric ectodomains of the T cell receptor complex enforce the conformation of juxtaposed segments.
Brazin KN; Mallis RJ; Li C; Keskin DB; Arthanari H; Gao Y; Wu SL; Karger BL; Wagner G; Reinherz EL
J Biol Chem; 2014 Jul; 289(27):18880-92. PubMed ID: 24849600
[TBL] [Abstract][Full Text] [Related]
6. Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function.
Nguyen P; Moisini I; Geiger TL
Blood; 2003 Dec; 102(13):4320-5. PubMed ID: 12946999
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: A double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression.
Boomer JS; Deppong CM; Shah DD; Bricker TL; Green JM
J Immunol; 2014 Apr; 192(8):3465-9. PubMed ID: 24639356
[TBL] [Abstract][Full Text] [Related]
8. Costimulatory receptors in a teleost fish: typical CD28, elusive CTLA4.
Bernard D; Riteau B; Hansen JD; Phillips RB; Michel F; Boudinot P; Benmansour A
J Immunol; 2006 Apr; 176(7):4191-200. PubMed ID: 16547256
[TBL] [Abstract][Full Text] [Related]
9. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R
Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453
[TBL] [Abstract][Full Text] [Related]
10. CD28 Signaling Drives Notch Ligand Expression on CD4 T Cells.
Mitra A; Shanthalingam S; Sherman HL; Singh K; Canakci M; Torres JA; Lawlor R; Ran Y; Golde TE; Miele L; Thayumanavan S; Minter LM; Osborne BA
Front Immunol; 2020; 11():735. PubMed ID: 32457739
[TBL] [Abstract][Full Text] [Related]
11. Superantigens hyperinduce inflammatory cytokines by enhancing the B7-2/CD28 costimulatory receptor interaction.
Levy R; Rotfogel Z; Hillman D; Popugailo A; Arad G; Supper E; Osman F; Kaempfer R
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6437-E6446. PubMed ID: 27708164
[TBL] [Abstract][Full Text] [Related]
12. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis but not other activation events is inhibited by a mutation in the transmembrane domain of T cell receptor beta that impairs CD3zeta association.
Rodríguez-Tarduchy G; Sahuquillo AG; Alarcón B; Bragado R
J Biol Chem; 1996 Nov; 271(48):30417-25. PubMed ID: 8940006
[TBL] [Abstract][Full Text] [Related]
14. Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.
Lynch A; Hawk W; Nylen E; Ober S; Autin P; Barber A
Immunology; 2017 Nov; 152(3):472-483. PubMed ID: 28670716
[TBL] [Abstract][Full Text] [Related]
15. Study of the interaction of the medium chain mu 2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28.
Follows ER; McPheat JC; Minshull C; Moore NC; Pauptit RA; Rowsell S; Stacey CL; Stanway JJ; Taylor IW; Abbott WM
Biochem J; 2001 Oct; 359(Pt 2):427-34. PubMed ID: 11583591
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of human CD28 in murine T cell hybridomas.
Couez D; Pagès F; Ragueneau M; Nunès J; Klasen S; Mawas C; Truneh A; Olive D
Mol Immunol; 1994 Jan; 31(1):47-57. PubMed ID: 8302298
[TBL] [Abstract][Full Text] [Related]
17. Dimerization of Kit-ligand and efficient cell-surface presentation requires a conserved Ser-Gly-Gly-Tyr motif in its transmembrane domain.
Paulhe F; Wehrle-Haller M; Jacquier MC; Imhof BA; Tabone-Eglinger S; Wehrle-Haller B
FASEB J; 2009 Sep; 23(9):3037-48. PubMed ID: 19386768
[TBL] [Abstract][Full Text] [Related]
18. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.
Prasad KV; Cai YC; Raab M; Duckworth B; Cantley L; Shoelson SE; Rudd CE
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2834-8. PubMed ID: 8146197
[TBL] [Abstract][Full Text] [Related]
19. The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28.
Muller YD; Nguyen DP; Ferreira LMR; Ho P; Raffin C; Valencia RVB; Congrave-Wilson Z; Roth TL; Eyquem J; Van Gool F; Marson A; Perez L; Wells JA; Bluestone JA; Tang Q
Front Immunol; 2021; 12():639818. PubMed ID: 33833759
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R
J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
